First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial

Trial StartPositive

AI Analysis

Summary

Ananda Pharma has dosed the first patient in a clinical trial for a cannabidiol-based treatment of chemotherapy-induced peripheral neuropathy. The trial represents early-stage development progress for the company's lead program in this indication.

Clinical Trial Data

Outcome Details

First patient dosed in CIPN clinical trial

Importance:4/10

Sentiment:

0.30

clinical trialcannabidiolCIPNtrial initiationUK pharma

Related Companies

$TRAX

Read the original article

Published by PR Newswire Clinical Trials on July 17, 2026 8:41 AM

Read Original